ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 114 filers reported holding ALBIREO PHARMA INC in Q3 2020. The put-call ratio across all filers is 7.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $221,756 | -2.3% | 7,434 | -23.7% | 0.00% | – |
| Q4 2021 | $227,000 | -24.3% | 9,743 | +1.5% | 0.00% | – |
| Q3 2021 | $300,000 | -15.7% | 9,601 | -5.3% | 0.00% | – |
| Q2 2021 | $356,000 | -2.7% | 10,133 | -2.3% | 0.00% | – |
| Q1 2021 | $366,000 | -6.6% | 10,373 | -0.7% | 0.00% | – |
| Q4 2020 | $392,000 | +45.7% | 10,451 | +29.5% | 0.00% | – |
| Q3 2020 | $269,000 | +18.5% | 8,072 | -3.1% | 0.00% | – |
| Q2 2020 | $227,000 | -1.3% | 8,329 | +16.9% | 0.00% | – |
| Q2 2019 | $230,000 | -14.5% | 7,125 | -5.9% | 0.00% | – |
| Q2 2018 | $269,000 | +2345.5% | 7,572 | +2057.3% | 0.00% | – |
| Q1 2018 | $11,000 | +22.2% | 351 | -0.3% | 0.00% | – |
| Q4 2017 | $9,000 | +28.6% | 352 | +1.1% | 0.00% | – |
| Q3 2017 | $7,000 | +600.0% | 348 | +582.4% | 0.00% | – |
| Q2 2017 | $1,000 | – | 51 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 270,146 | $6,627,000 | 3.42% |
| Perceptive Advisors | 1,704,330 | $39,506,000 | 1.50% |
| Birchview Capital, LP | 38,000 | $932,000 | 0.88% |
| SECTORAL ASSET MANAGEMENT INC | 229,978 | $5,641,000 | 0.77% |
| BVF INC/IL | 200,500 | $4,918,000 | 0.64% |
| Artal Group S.A. | 500,000 | $12,265,000 | 0.45% |
| PA Capital LLC | 14,692 | $360,000 | 0.38% |
| Chicago Capital, LLC | 180,911 | $4,438,000 | 0.36% |
| TPG Group Holdings (SBS) Advisors, Inc. | 716,381 | $17,573,000 | 0.28% |
| Fosun International Ltd | 197,005 | $4,492,000 | 0.27% |